We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Approach Developed to Diagnose Tuberculosis

By LabMedica International staff writers
Posted on 25 Mar 2015
The diagnosis of pulmonary tuberculosis (TB) usually includes laboratory analysis of sputum, a viscous material derived from deep in the airways of patients with active disease which can be difficult to collect and analyze by microbiological and molecular techniques. More...


An alternative, less invasive sample matrix could greatly simplify TB diagnosis, and as Mycobacterium tuberculosis cells or DNA accumulate on the oral epithelia of pulmonary TB patients, these can be collected and detected by using oral (buccal) swabs.

Scientists at the University of Washington (Seattle, WA, USA) working with colleagues in South Africa, collected three swabs each from 20 subjects with active pulmonary TB and from 20 healthy controls. The swabs (OmniSwab, Whatman; Maidstone, UK) were brushed along the inside of the subject's cheek for about 10 seconds (7 to 8 times) to collect cells and saliva. The head of each swab was ejected into a tube containing suitable solutions.

Samples were tested by using a polymerase chain reaction (qPCR) specific to the M. tuberculosis IS6110 insertion element and qPCR was performed on the StepOnePlus Real-Time PCR system (Applied Biosystems; Foster City, CA, USA) using the protocol of initial incubation at 95 °C for 10 minutes and 45 cycles of 95 °C for 15 seconds (denaturation) and 60 °C for one minute (annealing/extension).

Upon testing by oral swab PCR (OSP), 18 of the 20 case subjects (90%) yielded at least two swabs positive for M. tuberculosis DNA either in partial volume or full volume analyses. Of the 60 swab samples collected from the case group, 44 (73.3%) were positive. All control subjects were negative in all three swab samples per subject, in both the partial volume and full volume analyses (OSP). Sputum smear (acid fast) microscopy results were available for 17 of the 20 case subjects, of which 10 (59%) were smear positive. Specificity of OSP was 100% relative to the presumed disease-negative status of healthy controls.

The authors stressed that the study is merely a proof of principle, limited by its small size. Efforts are under way to expand this initial study into a large-scale controlled trial. Yet the preliminary success offers hope for greatly improved TB detection and control, especially in nations with limited public health resources, OSP could simplify the molecular diagnosis of TB and potentially be used for active TB case finding, made possible by the simple, noninvasive nature of the sampling method. The study was published on March 2, 2015, in the journal Scientific Reports.

Related Links:

University of Washington
Whatman
Applied Biosystems 



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.